// App-Quantinova.ai

: Expression of immune checkpoints on circulating tumor cells in men with metastatic prostate cancer (mPC).

Researchers

Presenter

  • Tian Zhang

Principal Investigators

  • Rebecca Garland Austin

  • Sally E Park

  • Daniella Runyambo

  • Rengasamy Boominathan

  • Chandra Rao

  • Elizabeth Bronson

  • Monika Anand

  • Patrick Healy

  • Daniel J. George

  • Megan Ann McNamara

  • Andrew J. Armstrong

Medical Centers

  • Duke University Medical Center, Durham, NC

  • Emory University School of Medicine, Atlanta, GA

  • Albert Einstein College of Medicine, Great Neck, NY

  • Duke Cancer Institute, Duke University Medical Center, Durham, NC

  • Veridex LLC, Huntingdon Valley, PA

  • Duke University, Durham, NC

  • Duke University Medical Center, Mornsville, NC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • B7 homolog 3

  • Circulating tumor cells

  • Programmed cell death 1 ligand 2

  • Programmed death-ligand 1

  • Cytotoxic T-lymphocyte-associated protein 4

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • CB-7598

  • Sipuleucel-T

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved